Article Text
Pain management
Randomised controlled trial
Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent
Statistics from Altmetric.com
Footnotes
-
Competing interests CPC is on the Advisory Board and Speakers Bureau for Meda Pharmaceuticals.